Anteris Technologies Global Corp. (NASDAQ:AVR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) have earned an average recommendation of “Moderate Buy” from the five analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $16.00.

A number of equities research analysts have commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Barclays increased their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Wall Street Zen upgraded shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a report on Friday, August 14th.

Anteris Technologies Global Stock Down 2.9%

Shares of Anteris Technologies Global stock opened at $8.98 on Friday. The stock has a market cap of $875.19 million, a PE ratio of -4.61 and a beta of 1.78. The business has a fifty day simple moving average of $9.14 and a 200-day simple moving average of $7.49. Anteris Technologies Global has a 12 month low of $3.30 and a 12 month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). The business had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter in the prior year, the firm posted ($0.58) EPS. Analysts expect that Anteris Technologies Global will post -1.21 EPS for the current fiscal year.

Insider Transactions at Anteris Technologies Global

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 375,815 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50. Following the completion of the sale, the insider owned 4,811,341 shares in the company, valued at $44,745,471.30. This represents a 7.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders have sold 3,000,659 shares of company stock valued at $25,174,702. 4.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Anteris Technologies Global

A number of hedge funds have recently modified their holdings of AVR. Nantahala Capital Management LLC acquired a new stake in Anteris Technologies Global during the second quarter valued at $33,325,850,000. One68 Global Capital LLC purchased a new position in Anteris Technologies Global in the second quarter valued at about $128,000. Bank of America Corp DE acquired a new position in Anteris Technologies Global in the 2nd quarter worth about $1,907,000. AWM Investment Company Inc. acquired a new position in Anteris Technologies Global in the 2nd quarter worth about $1,133,000. Finally, ADAR1 Capital Management LLC purchased a new stake in shares of Anteris Technologies Global during the 2nd quarter worth about $30,979,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.